Robert J. Polzer - 08 Feb 2023 Form 4 Insider Report for Zoetis Inc. (ZTS)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
10 Feb 2023, 17:30:47 UTC
Prior SEC filing
18 Jan 2023
Next SEC filing
14 Feb 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Brenda Santuccio, as Attorney-in-Fact

Key filing fact

Robert J. Polzer filed Form 4 for Zoetis Inc. (ZTS) on 10 Feb 2023.

Key facts

  • This page summarizes Robert J. Polzer's Form 4 filing for Zoetis Inc. (ZTS).
  • 3 reported transactions and 5 derivative rows are listed below.
  • Accepted by SEC: 10 Feb 2023, 17:30.

Change

  • Previous filing in this sequence was filed on 18 Jan 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ZTS transaction Derivative

Performance Award Unit

Award

Transaction value
$0
Shares
+349
Change %
Price
$0.000000
Shares after
349
Date
08 Feb 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
349
Exercise price
Footnotes
F1, F2, F3, F4
ZTS transaction Derivative

Restricted Stock Unit

Award

Transaction value
$0
Shares
+1,951
Change %
Price
$0.000000
Shares after
1,951
Date
08 Feb 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,951
Exercise price
Footnotes
F4, F5, F6, F7
ZTS transaction Derivative

Stock Option

Award

Transaction value
$0
Shares
+7,260
Change %
Price
$0.000000
Shares after
7,260
Date
08 Feb 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
7,260
Exercise price
$162.07
Footnotes
F11, F12, F13
ZTS holding Derivative

Restricted Stock Unit

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,931
Date
08 Feb 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,931
Exercise price
Footnotes
F4, F6, F8, F9, F10
ZTS holding Derivative

Stock Option

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
7,691
Date
08 Feb 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
7,691
Exercise price
Footnotes
F13, F14, F15, F16
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 16 footnotes

Footnote F1

Represents performance award units with a three-year performance period covering 2020-2022 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 8, 2023, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 11, 2023, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

Footnote F2

Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock.

Footnote F3

Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 11, 2023 subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

Footnote F4

Not applicable.

Footnote F5

Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). One-third of the RSUs vest and are settled in shares of Zoetis common stock on each of the first, second and third anniversaries of the date of grant, respectively, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

Footnote F6

Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.

Footnote F7

One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

Footnote F8

Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). RSUs vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

Footnote F9

Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject toearlier vesting and settlement upon certain specific events.

Footnote F10

The RSUs vest as follows: 282.3532 RSUs will vest on February 11, 2023; 252.3747 will vest on February 10, 2024; and 1,396.0802 RSUs will vest on February 8, 2025.

Footnote F11

Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan.

Footnote F12

One-third of each option will vest on the first, second and third anniversaries of the date of grant.

Footnote F13

Each option expires on the tenth anniversary of the date of grant.

Footnote F14

Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan.

Footnote F15

1,179 options granted February 11, 2020 at an exercise price of $144.03 per option; 1,057 options granted February 10, 2021 at an exercise price of $160.62 per option; and 5,455 options granted February 8, 2022 at an exercise price of $201.30 per option.

Footnote F16

Each option vests on the third anniversary of the date of grant.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .